95% SpO2 | 96% SpO2 | 97% SpO2 | 98% SpO2 | p | |
---|---|---|---|---|---|
PMA < 33 | |||||
n | 175 | 154 | 150 | 126 | |
Risk > 80 (%) | 18% (12–23%) | 12% (7–18%) | 37% (30–45%) | 45% (34–54%) | < 0.001 |
Risk > 99 (%) | 7% (3–11%) | 4% (1–7%) | 14% (8–20%) | 25% (18–33%) | < 0.001 |
PaO2 | 63 (54–73) | 62 (54–73) | 71 (60–88) | 80 (63–100) | < 0.001 |
PMA 33–36 | |||||
n | 156 | 172 | 190 | 225 | |
Risk > 80 (%) | 28% (0.21–0.35) | 26% (19–32%) | 0.43 (36–50%) | 0.61 (54–67%) | < 0.001 |
Risk > 99 (%) | 10% (6–15%) | 13% (8–18%) | 20% (14–25%) | 34% (28–40%) | < 0.001 |
PaO2 | 68 (61–81) | 70 (62–81) | 79 (67–92) | 86 (73–108) | < 0.001 |
PMA > 36 | |||||
n | 959 | 1156 | 1483 | 1729 | |
Risk > 80 (%) | 28% (25–31%) | 42% (39–45%) | 56% (53–58%) | 70% (68–72%) | < 0.001 |
Risk > 99 (%) | 14% (10–14%) | 20% (17–22%) | 28% (26–30%) | 42% (41–45%) | < 0.001 |
PaO2 | 70 (61–83) | 76 (65–93) | 84 (70–103) | 94 (78–124) | < 0.001 |